NCT04661904

Brief Summary

To investigate the impact of cTBS on the incidence of postoperative delirium and changes of cognitive function in elderly patients after surgery. To explore whether short-term cTBS can reduce the risk of postoperative delirium as a preventive strategy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 10, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

July 7, 2021

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2024

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2024

Completed
Last Updated

August 15, 2025

Status Verified

April 1, 2025

Enrollment Period

3.4 years

First QC Date

November 26, 2020

Last Update Submit

August 14, 2025

Conditions

Keywords

postoperative deliriumcontinuous theta burst stimulation

Outcome Measures

Primary Outcomes (3)

  • Incidence of postoperative delirium

    Incidence of postoperative delirium on postoperative day 1, 2 and 3 was defined according to the confusion assessment methods (CAM).

    3 days after surgery

  • Cognitive function related to delirium

    The cognitive function related to delirium was assessed by using Delirium Symptom Interview Daily (DSI Daily).

    3 days after surgery

  • Severity of postoperative delirium

    Severity of postoperative delirium on postoperative day 1, 2 and 3 was defined according to he Confusion Assessment Method based delirium severity evaluation tool (CAM-S).The sum score of CAM-S ranges from 0 (no) to 19 (most severe).

    3 days after surgery

Secondary Outcomes (4)

  • Pain level

    3 days after surgery

  • Sleep quality

    3 days after surgery

  • Ability of daily living

    up to 7 days after anesthesia/surgery

  • Rate of complication and mortality

    up to 7 days after anesthesia/surgery

Study Arms (2)

cTBS group

EXPERIMENTAL

Patients randomly assigned to cTBS group received 9 sessions cTBS for total three days after surgery.

Device: Continuous theta burst stimulation (cTBS)

sham group

SHAM COMPARATOR

Patients randomly assigned to sham group received 9 sessions sham stimulation for total three days after surgery.

Device: Sham stimulation

Interventions

Our active treatment consisted of 600 pulses per session, delivered over the right dorsolateral prefrontal cortex at 80% of resting motor threshold (RMT). Every session cTBS consists of 50 Hz triplets of pulses delivered at 5 Hz for 40 seconds for a total of 600 pulses. Every set simulation includes 3 sessions. All enrolled patient in the cTBS group received 1 set simulation per day with an intersession interval (ISI) of over 30 minutes during the hospitalization after the surgery. The first set of stimulation was given at 4 hours after the end of surgery on the day of surgery. The other sets of stimulation were given at 8 am, 8:30 am and 9:00 am on postoperative day 1and 2, respectively.

cTBS group

The sham stimulation group received a sham cTBS (600 pulses per session, 3 sessions per day, ISI ≥ 30mins, 3 days) with the coil set at 90 against the skull. The first set of stimulation was given at 4 hours after the end of surgery on the day of surgery. The other sets of stimulation were given at 8 am, 8:30 am and 9:00 am on postoperative day 1 and 2, respectively.

sham group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Participants were included if they: 1. were 65 years old or older; 2. had orthopedic surgery under general anesthesia; 3. had normal cognitive function at enrolment \[for illiterate, Mini-Mental State Examination (MMSE) ≥ 17; for individuals with 1-6 years of education, MMSE ≥ 20; for individuals with 7 or more years of education, MMSE ≥ 24\]; 4. were able to complete cognitive assessments and the Confusion Assessment Method (CAM); 5. Chinese Mandarin as their native language; 6. were willing to participate and being competent to provide informed consent. Patients were excluded if they: 1. had delirium assessed by CAM before surgery; 2. had neurological diseases (e.g., stroke, Parkinson's disease, etc.) according to International Statistical Classification of Diseases and Related Health Problems 11th Revision (ICD-11); 3. had mental disorders (e.g., major depressive disorder, dementia, etc.) according to Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5); 4. had contraindications of cTBS (e.g., head trauma, history of epilepsy or metal implants in the head); 5. participating in other clinical studies at the time of screening; 6. having postoperative complications such as pulmonary infection, pulmonary embolism and stroke.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Shanghai 10th People's Hospital

Shanghai, Shanghai Municipality, 200072, China

Location

Related Publications (1)

  • Wei X, Wang M, Ma X, Tang T, Shi J, Zhao D, Yuan T, Xie Z, Shen Y. Treatment of postoperative delirium with continuous theta burst stimulation: study protocol for a randomised controlled trial. BMJ Open. 2021 Aug 16;11(8):e048093. doi: 10.1136/bmjopen-2020-048093.

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Yuan Shen, MD, PhD

    Shanghai, Shanghai, China, 200072

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Psychiatry

Study Record Dates

First Submitted

November 26, 2020

First Posted

December 10, 2020

Study Start

July 7, 2021

Primary Completion

December 2, 2024

Study Completion

December 13, 2024

Last Updated

August 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations